Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias
Clinical Trial Grant
Duke Scholars
Principal Investigator
Harry Paul Erba
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
PTC Therapeutics, Inc
Start Date
January 7, 2020
End Date
April 10, 2024
Awarded By
PTC Therapeutics, Inc
Start Date
January 7, 2020
End Date
April 10, 2024
